Clinical Updates in ALL

 

ecancer
N

EHA 2022: Ponatinib & Blinatumomab for Patients With Ph+ ALL

By ecancer FEATURING Nicholas Short
By ecancer FEATURING Nicholas Short
142 views
June 24, 2022
0 Comments
Login to view comments. Click here to Login
Clinical Updates in ALL
13:46
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Management of Ph+ ALL in 2022

Feat. E. Jabbour
06:35
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Phase II Study of Blinatumomab in Combination With Ponati…

Feat. F. Haddad
12:49
SOHO 2022 Tenth Annual Meeting

SOHO 2022: Approach to Ph-Like ALL

Feat. E. Curran
09:08
Selina Luger

Approaches to and Use of MRD in ALL

10:33
Lori Muffly

Next Questions: ALL

14:24
Jonathan Webster

2022 NCCN Guidelines Updates on MRD Testing in ALL

01:25
Jonathan Webster

Lecture Summary - 2022 NCCN Guidelines Updates on MRD Testing in ALL

11:51
Emily Curran

Eliminating MRD in Adults With ALL Prior to Transplant: Practical Ap…

10:21
Nicholas Short

Eliminating MRD Prior to HSCT in ALL: Strategies and Considerations

01:10
Nicholas Short

Lecture Summary - Eliminating MRD Prior to HSCT in ALL: Strategies a…

16:32
UChicago Medicine

Personalizing Therapeutic Approaches in Leukemia and Myeloid Maligna…

Feat. A. Patel
13:56
Hagop Kantarjian

Adult ALL: Progress in Research and Therapy

06:01
ecancer

EHA 2022: Ponatinib & Blinatumomab for Patients With Ph+ ALL

Feat. N. Short
04:11
Total Health

ASCO 2022 Updates in Leukemia and MDS

Feat. D. Sallman
04:22
EHA 2022 Conference Coverage

EHA 2022 Tamibarotene in Combination With Ven & Aza in Previousl…

Feat. E. Stein
06:42
ASCO 2022 Conference Coverage

ASCO 2022 Updates on the Evolution of Asparaginase in the Management…

Feat. R. Cassaday
56
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Updates on the Evolution of Asparaginase…

Feat. R. Cassaday
14:49
Penn Medicine Abramson Cancer Center

The Direction of Leukemia Treatment Nationally and Around the World:…

Feat. S. Luger
06:25
Hugo Akabane

ALL and Awareness Around MRD

16:32
Rachel Rau

Chemotherapy vs. Blinatumomab in R/R B-ALL

24:40
ASH 2021 Conference Coverage on VuMedi

ASH 2021 Update on MRD in ALL: Standard of Care & Areas for Furt…

Feat. L. Muffly
15:51
Ryan Cassaday

MRD in Children and Young Adults With High-Risk ALL

08:36
Elias Jabbour

Updates on Treatment Sequencing in ALL

11:32
SOHO 3rd Italian Conference

SOHO Italy 2021: Chemotherapy Free Regimens in Ph+ ALL

Feat. S. Chiaretti
13:29
Society of Hematologic Oncology Ninth Annual Meeting (SOHO 2021)

SOHO 2021 Next Questions in ALL

Feat. B. Shah
13:15
SOHO 3rd Italian Conference

SOHO Italy 2021 on Triple Negative ALL: Past, Present, and Future

Feat. A. Ferrari